To improve workflow, dose management and overall image quality
GE Healthcare has reported the first planned clinical installation of the new Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management and overall image quality. The system combines GE Healthcare’s BrightSpeed Elite16 slice CT, a newly designed Spect gantry for greater positional flexibility, and the latest advancements in Nuclear Medicine detectors.
The company claims that the Discovery NM/CT 670 has the capability to shorten acquisition times, improve dose management, and enable more convenient patient scheduling in comparison to separate, conventional SPECT and CT exams. The Discovery NM/CT 670 is 510(k) pending at the FDA. It is not available for sale in the US.
The company said that keeping the patient in mind, the system can reduce scan time. Bone imaging protocols, including planar whole body, two-Fov Spect and CT attenuation correction/localisation, are among the most frequently performed Nuclear Medicine procedures. With the Discovery NM/CT 670, the time can be reduced to as little as 25 minutes.
Nathan Hermony, general manager of nuclear medicine business of GE Healthcare, said: “Ten years ago, we introduced the Spect/CT. With the Discovery NM/CT 670, we are providing clinicians the ability to perform both hybrid imaging and standalone CT procedures.
“We understand that a clinician does not want to compromise. We are providing the latest in Spect and CT technology so clinicians can explore new dimensions of disease and provide the best possible treatment and monitoring of the patient.”